Phosphodiesterase type 5 inhibitors for the treatment of sexual dysfunction in males with major depressive disorder: A systematic review and meta‐analysis
Gespeichert in:
| Veröffentlicht in: | Psychiatry and clinical neurosciences 2023-05, Vol.77 (5), p.297-299 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 299 |
|---|---|
| container_issue | 5 |
| container_start_page | 297 |
| container_title | Psychiatry and clinical neurosciences |
| container_volume | 77 |
| creator | Sakuma, Kenji Kishi, Taro Sanji, Shohei Nomura, Ikuo Hatano, Masakazu Okuya, Makoto Iwata, Nakao |
| description | |
| doi_str_mv | 10.1111/pcn.13537 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2778980082</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2808456488</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3377-a194a2c45f6151bbfc9d9ef60dcea5452d1ba0104807414b79ff24e10e8d9aa43</originalsourceid><addsrcrecordid>eNp1kU9u1TAQxi0EoqWw4ALIEhtYpLVjJ3HYVU_8kyroAtaRY48VPyVx8Dh9zY4jcABOx0kwvMICidnMSPObb0bzEfKUs3Oe42Ix8zkXlWjukVMuJSu44u39XItSFFzw-oQ8QtwzxoSo-UNyImrFalGLU_L9egi4DMF6wARRI9C0LUAr6ufB9z6FiNSFSNOQOxF0mmBONDiKcLvqkdoN3Tqb5MOcR-ikR0B68GnI5T7PWVgiIPoboNZjiBbiK3pJccvrJp28oRFuPByoni2dIOkfX7_pWY8benxMHjg9Ijy5y2fk85vXn3bviquPb9_vLq8KI0TTFJq3UpdGVq7mFe97Z1rbgquZNaArWZWW95pxJhVrJJd90zpXSuAMlG21luKMvDjqLjF8WfMjusmjgXHUM4QVu7JpVKsYU2VGn_-D7sMa872ZUkzJqpZKZerlkTIxIEZw3RL9pOPWcdb9sqzLlnW_LcvsszvFtZ_A_iX_eJSBiyNw8CNs_1fqrncfjpI_ARccpEY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2808456488</pqid></control><display><type>article</type><title>Phosphodiesterase type 5 inhibitors for the treatment of sexual dysfunction in males with major depressive disorder: A systematic review and meta‐analysis</title><source>MEDLINE</source><source>Freely Accessible Japanese Titles</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Wiley Online Library Free Content</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Sakuma, Kenji ; Kishi, Taro ; Sanji, Shohei ; Nomura, Ikuo ; Hatano, Masakazu ; Okuya, Makoto ; Iwata, Nakao</creator><creatorcontrib>Sakuma, Kenji ; Kishi, Taro ; Sanji, Shohei ; Nomura, Ikuo ; Hatano, Masakazu ; Okuya, Makoto ; Iwata, Nakao</creatorcontrib><identifier>ISSN: 1323-1316</identifier><identifier>EISSN: 1440-1819</identifier><identifier>DOI: 10.1111/pcn.13537</identifier><identifier>PMID: 36806363</identifier><language>eng</language><publisher>Melbourne: John Wiley & Sons Australia, Ltd</publisher><subject>Depressive Disorder, Major - complications ; Depressive Disorder, Major - drug therapy ; Humans ; Male ; Mental depression ; Meta-analysis ; Phosphodiesterase 5 Inhibitors - pharmacology ; Phosphodiesterase 5 Inhibitors - therapeutic use ; Systematic review</subject><ispartof>Psychiatry and clinical neurosciences, 2023-05, Vol.77 (5), p.297-299</ispartof><rights>2023 The Authors. Psychiatry and Clinical Neurosciences © 2023 Japanese Society of Psychiatry and Neurology.</rights><rights>2023 Japanese Society of Psychiatry and Neurology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3377-a194a2c45f6151bbfc9d9ef60dcea5452d1ba0104807414b79ff24e10e8d9aa43</cites><orcidid>0000-0001-7032-878X ; 0000-0002-9237-2236</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fpcn.13537$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fpcn.13537$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36806363$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sakuma, Kenji</creatorcontrib><creatorcontrib>Kishi, Taro</creatorcontrib><creatorcontrib>Sanji, Shohei</creatorcontrib><creatorcontrib>Nomura, Ikuo</creatorcontrib><creatorcontrib>Hatano, Masakazu</creatorcontrib><creatorcontrib>Okuya, Makoto</creatorcontrib><creatorcontrib>Iwata, Nakao</creatorcontrib><title>Phosphodiesterase type 5 inhibitors for the treatment of sexual dysfunction in males with major depressive disorder: A systematic review and meta‐analysis</title><title>Psychiatry and clinical neurosciences</title><addtitle>Psychiatry Clin Neurosci</addtitle><subject>Depressive Disorder, Major - complications</subject><subject>Depressive Disorder, Major - drug therapy</subject><subject>Humans</subject><subject>Male</subject><subject>Mental depression</subject><subject>Meta-analysis</subject><subject>Phosphodiesterase 5 Inhibitors - pharmacology</subject><subject>Phosphodiesterase 5 Inhibitors - therapeutic use</subject><subject>Systematic review</subject><issn>1323-1316</issn><issn>1440-1819</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kU9u1TAQxi0EoqWw4ALIEhtYpLVjJ3HYVU_8kyroAtaRY48VPyVx8Dh9zY4jcABOx0kwvMICidnMSPObb0bzEfKUs3Oe42Ix8zkXlWjukVMuJSu44u39XItSFFzw-oQ8QtwzxoSo-UNyImrFalGLU_L9egi4DMF6wARRI9C0LUAr6ufB9z6FiNSFSNOQOxF0mmBONDiKcLvqkdoN3Tqb5MOcR-ikR0B68GnI5T7PWVgiIPoboNZjiBbiK3pJccvrJp28oRFuPByoni2dIOkfX7_pWY8benxMHjg9Ijy5y2fk85vXn3bviquPb9_vLq8KI0TTFJq3UpdGVq7mFe97Z1rbgquZNaArWZWW95pxJhVrJJd90zpXSuAMlG21luKMvDjqLjF8WfMjusmjgXHUM4QVu7JpVKsYU2VGn_-D7sMa872ZUkzJqpZKZerlkTIxIEZw3RL9pOPWcdb9sqzLlnW_LcvsszvFtZ_A_iX_eJSBiyNw8CNs_1fqrncfjpI_ARccpEY</recordid><startdate>202305</startdate><enddate>202305</enddate><creator>Sakuma, Kenji</creator><creator>Kishi, Taro</creator><creator>Sanji, Shohei</creator><creator>Nomura, Ikuo</creator><creator>Hatano, Masakazu</creator><creator>Okuya, Makoto</creator><creator>Iwata, Nakao</creator><general>John Wiley & Sons Australia, Ltd</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7032-878X</orcidid><orcidid>https://orcid.org/0000-0002-9237-2236</orcidid></search><sort><creationdate>202305</creationdate><title>Phosphodiesterase type 5 inhibitors for the treatment of sexual dysfunction in males with major depressive disorder: A systematic review and meta‐analysis</title><author>Sakuma, Kenji ; Kishi, Taro ; Sanji, Shohei ; Nomura, Ikuo ; Hatano, Masakazu ; Okuya, Makoto ; Iwata, Nakao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3377-a194a2c45f6151bbfc9d9ef60dcea5452d1ba0104807414b79ff24e10e8d9aa43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Depressive Disorder, Major - complications</topic><topic>Depressive Disorder, Major - drug therapy</topic><topic>Humans</topic><topic>Male</topic><topic>Mental depression</topic><topic>Meta-analysis</topic><topic>Phosphodiesterase 5 Inhibitors - pharmacology</topic><topic>Phosphodiesterase 5 Inhibitors - therapeutic use</topic><topic>Systematic review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sakuma, Kenji</creatorcontrib><creatorcontrib>Kishi, Taro</creatorcontrib><creatorcontrib>Sanji, Shohei</creatorcontrib><creatorcontrib>Nomura, Ikuo</creatorcontrib><creatorcontrib>Hatano, Masakazu</creatorcontrib><creatorcontrib>Okuya, Makoto</creatorcontrib><creatorcontrib>Iwata, Nakao</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Psychiatry and clinical neurosciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sakuma, Kenji</au><au>Kishi, Taro</au><au>Sanji, Shohei</au><au>Nomura, Ikuo</au><au>Hatano, Masakazu</au><au>Okuya, Makoto</au><au>Iwata, Nakao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phosphodiesterase type 5 inhibitors for the treatment of sexual dysfunction in males with major depressive disorder: A systematic review and meta‐analysis</atitle><jtitle>Psychiatry and clinical neurosciences</jtitle><addtitle>Psychiatry Clin Neurosci</addtitle><date>2023-05</date><risdate>2023</risdate><volume>77</volume><issue>5</issue><spage>297</spage><epage>299</epage><pages>297-299</pages><issn>1323-1316</issn><eissn>1440-1819</eissn><cop>Melbourne</cop><pub>John Wiley & Sons Australia, Ltd</pub><pmid>36806363</pmid><doi>10.1111/pcn.13537</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0001-7032-878X</orcidid><orcidid>https://orcid.org/0000-0002-9237-2236</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1323-1316 |
| ispartof | Psychiatry and clinical neurosciences, 2023-05, Vol.77 (5), p.297-299 |
| issn | 1323-1316 1440-1819 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2778980082 |
| source | MEDLINE; Freely Accessible Japanese Titles; Wiley Online Library Journals Frontfile Complete; Wiley Online Library Free Content; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Depressive Disorder, Major - complications Depressive Disorder, Major - drug therapy Humans Male Mental depression Meta-analysis Phosphodiesterase 5 Inhibitors - pharmacology Phosphodiesterase 5 Inhibitors - therapeutic use Systematic review |
| title | Phosphodiesterase type 5 inhibitors for the treatment of sexual dysfunction in males with major depressive disorder: A systematic review and meta‐analysis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T17%3A30%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phosphodiesterase%20type%205%20inhibitors%20for%20the%20treatment%20of%20sexual%20dysfunction%20in%20males%20with%20major%20depressive%20disorder:%20A%20systematic%20review%20and%20meta%E2%80%90analysis&rft.jtitle=Psychiatry%20and%20clinical%20neurosciences&rft.au=Sakuma,%20Kenji&rft.date=2023-05&rft.volume=77&rft.issue=5&rft.spage=297&rft.epage=299&rft.pages=297-299&rft.issn=1323-1316&rft.eissn=1440-1819&rft_id=info:doi/10.1111/pcn.13537&rft_dat=%3Cproquest_cross%3E2808456488%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2808456488&rft_id=info:pmid/36806363&rfr_iscdi=true |